PNC Financial Services Group
TYRA icon

PNC Financial Services Group’s Tyra Biosciences TYRA Stock Holding History

PNC Financial Services Group’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.54K Buy
223
+15
+7% +$486 ﹤0.01% 4024
2025
Q4 		$5.47K Hold
208
– – ﹤0.01% 4200
2025
Q3 		$2.91K Buy
208
+150
+259% +$1.71K ﹤0.01% 4399
2025
Q2 		$555 Hold
58
– – ﹤0.01% 4668
2025
Q1 		$539 Hold
58
– – ﹤0.01% 4629
2024
Q4 		$806 Hold
58
– – ﹤0.01% 4467
2024
Q3 		$1.36K Hold
58
– – ﹤0.01% 4382
2024
Q2 		$927 Hold
58
– – ﹤0.01% 4442
2024
Q1 		$951 Hold
58
– – ﹤0.01% 4371
2023
Q4 		$803 Hold
58
– – ﹤0.01% 4348
2023
Q3 		$799 Hold
58
– – ﹤0.01% 4416
2023
Q2 		$988 Hold
58
– – ﹤0.01% 4514
2023
Q1 		$932 Hold
58
– – ﹤0.01% 4450
2022
Q4 		$441 Hold
58
– – ﹤0.01% 4545
2022
Q3 		$1K Hold
58
– – ﹤0.01% 4352
2022
Q2 		$0 Buy
+58
New +$462 ﹤0.01% 4719

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

PNC Financial Services Group's TYRA Position: Q1 2026 in Review

PNC Financial Services Group increased its Tyra Biosciences (TYRA) stake by 7.2% in Q1 2026, buying an estimated $486 and bringing the position to 223 shares worth $8.54K. The position accounts for ﹤0.01% of the portfolio, ranked #4024.

PNC Financial Services Group first reported a position in TYRA in Q2 2022 and has held it in 16 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • PNC Financial Services Group held 223 shares of Tyra Biosciences worth $8.54K as of Q1 2026.
  • PNC Financial Services Group bought 15 Tyra Biosciences shares in Q1 2026, an estimated $486.
  • Tyra Biosciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #4024 holding.
  • PNC Financial Services Group first reported a position in Tyra Biosciences in Q2 2022 and has held it in 16 quarters since.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.